ESR1 and cancer: The converse, the importance of immune cell activity and interactions with the extracellular matrix in the response to reduced estrogenic activity, was shown in a recent study designed to identify features of ER+ cancers that predict de novo resistance to suppression of proliferation by AIs (luminal B cancers) [69].